SLC7A11 and Crohn disease: Sulfasalazine, used for inflammatory diseases such as ulcerative colitis and Crohn’s disease, is considered to specifically inhibit cystine transport via xCT, thereby selectively controlling the proliferation of cancer cells expressing CD44v [61].